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Lactic acid bacteria (LAB) can produce a huge amount of bioactive compounds. Since
their elective habitat is food, especially dairy but also vegetal food, it is frequent to find
bioactive molecules in fermented products. Sometimes these compounds can have
adverse effects on human health such as biogenic amines (tyramine and histamine),
causing allergies, hypertensive crises, and headache. However, some LAB products
also display benefits for the consumers. In the present review article, the main nitrogen
compounds produced by LAB are considered. Besides biogenic amines derived from
the amino acids tyrosine, histidine, phenylalanine, lysine, ornithine, and glutamate by
decarboxylation, interesting peptides can be decrypted by the proteolytic activity of
LAB. LAB proteolytic system is very efficient in releasing encrypted molecules from
several proteins present in different food matrices. Alpha and beta-caseins, albumin and
globulin from milk and dairy products, rubisco from spinach, beta-conglycinin from soy
and gluten from cereals constitute a good source of important bioactive compounds.
These encrypted peptides are able to control nutrition (mineral absorption and oxidative
stress protection), metabolism (blood glucose and cholesterol lowering) cardiovascular
function (antithrombotic and hypotensive action), infection (microbial inhibition and
immunomodulation) and gut-brain axis (opioids and anti-opioids controlling mood and
food intake). Very recent results underline the role of food-encrypted peptides in
protein folding (chaperone-like molecules) as well as in cell cycle and apoptosis control,
suggesting new and positive aspects of fermented food, still unexplored. In this context,
the detailed (transcriptomic, proteomic, and metabolomic) characterization of LAB of
food interest (as starters, biocontrol agents, nutraceuticals, and probiotics) can supply a
solid evidence-based science to support beneficial effects and it is a promising approach
as well to obtain functional food. The detailed knowledge of the modulation of human
physiology, exploiting the health-promoting properties of fermented food, is an open
field of investigation that will constitute the next challenge.
Keywords: opioid, antioxidant, chaperon-like, cell-cycle control, antimicrobial peptides, beta-phenylethylamine,
tyramine
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INTRODUCTION
Human health is the result of a correct physiological status
often resulting from the reciprocal interaction of gene-derived
signals (genetics) and environment–generated information
(epigenetics). Recognizing gene signals is relatively easy
whereas environmental stimuli are often multiple, complex,
and reciprocally interacting. Temperature, pH, redox balance,
sleep, diet, drugs, and psychological status can deeply affect
gene expression, metabolic pathways, and homeostasis (Carey,
2012). However, human genes and environment are not the only
players: microorganisms can take part to the complex molecular
cross-talk existing between external world and “self.”
Firstly, endogenous symbiont microorganisms, the so-called
microbiota, can modulate gene expression, induce preferential
food intake (Aydin, 2007), influence pH, redox balance and
the ratio between pro-inflammatory and anti-inflammatory
cytokines (Belkaid and Hand, 2014). Briefly, control brain,
metabolism, immune system, and several homeostatic routes.
Secondarily, food-derived bacteria and yeasts can exogenously
affect nutritional parameters, metabolism, oxidative status,
immunity, blood pressure, appetite, behavior, also controlling the
endogenous microbiota (Arora et al., 2013) by altering the ratio
among saccharolytic and proteolytic species, by modulating
symbionts gene expression and several other functions
(O’Flaerty, 2014). Hence, all fermented food, containing
living organisms, can contribute to modulation of the host
physiological balance and it constitutes an opportunity to
enrich the diet with new bioactive molecules finally resulting
in phenotypic effects (appetite, cholesterol and blood pressure
lowering, improvement of mood, antioxidant, and immune
defenses) on humans (Pessione, 2010). Actually, all types of
modulations occur via a complex network of signals, among
which proteinaceous compounds play a crucial role.
Microorganisms are able to synthesize a large number of
metabolites with assessed beneficial or detrimental properties for
human health. Among these, nitrogen-bearing molecules such
as amino acids, amino acid derivatives and oligopeptides have
received great attention since they can affect human physiology
in multiple ways.
As an example, amino acid derivatives such as selenocysteines
and selenomethionines, have recently been reported to be
biosynthesized in both Lactobacilli (Lamberti et al., 2011) and
yeasts (Porto et al., 2015). Although selenoaminoacids are not
true “bioactive compounds,” directly stimulating receptors on
human cells, they can trigger effects deeply affecting human
health. The bioactive role of seleno-fixing microorganisms lies
in the fact that diet-derived inorganic selenium is toxic (selenate
and selenite) or poorly active (elemental selenium) whereas
fixed selenium forms (selenomethionines and selenocysteines)
are the only bioavailable for humans. On the other hand,
only bacteria and yeasts can produce seleno-amino acids from
inorganic selenium. Once properly inserted into selenoproteins
(i.e., glutathione peroxidase), they can counteract oxidative stress.
Besides this well-known antioxidant function, there are data
indicating that selenoproteins can modulate immune system
(Huang et al., 2012) and activating anabolic circuits such as
thyroid hormone biosynthesis (Mullur et al., 2014). Furthermore,
epidemiological studies show an inverse correlation between
selenium level in blood and cancer mortality, and laboratory
experiments have shown a selenium protective effect against
cancer initiation and development (Gromadzin´ska et al., 2008).
In Lactobacillus reuteri exoproteome studies have demonstrated
that two secreted proteins (GAPDH and Phosphoketolase)
contain selenocysteines opening the way to employ this strain
to supply organic bioavailable forms of selenium (Galano et al.,
2013; Mangiapane et al., 2014a,b).
Among amino acid derivatives found in food, biogenic amines
are worth of a special mention. Such compounds, although
sometimes naturally present (especially in vegetal food) are
often the result of the bacterial decarboxylative activity on
free amino acids in food. Biogenic amines can be present in
non-fermented food, like fish, due to spoilage bacteria that
during protein putrefaction release free amino acids undergoing
decarboxylation. E. coli can produce cadaverine from lysine and
putrescine from ornithine (Applebaum et al., 1975). Proteus
can produce putrescine from ornithine as a communication
signal (Visick and Fuqua, 2005). However, also not-spoiled
food, such as fermented food, can present the risk of biogenic
amine accumulation. Although starters, exogenously added to
perform controlled fermentations, are accurately typed to avoid
any risk, autochthonous or contaminant lactic acid bacteria
(LAB) can contribute to amine release. LAB are strong amine
producers since they use this metabolic pathway (at the place of
respiration) to both create a proton gradient and hence energy
(for exhaustive review, see Pessione et al., 2010) and to alkalinize
the environment, very acidic since their main fermentation
products are acids (lactic acid for homofermenter LAB and
lactic+ formic+ acetic acid in heterofermenters).
Many experimental evidences demonstrate that some
LAB strains also produce anti-hypertensive, anti-thrombotic,
cholesterol-lowering, metal-chelating, antimicrobial, anti-
oxidant, immune-modulating, chaperone-like and opioid/opioid
antagonist peptides from food proteins (Pessione, 2012), and
they can modulate the concentration of opioid and cannabinoid
receptors in the gut epithelium (Hayes et al., 2007b). The next
sections will focus on some of the referred compounds and will
illustrate the main effects exerted on human health.
ENCRYPTED BIOACTIVE PEPTIDES
Several bioactive peptides, lacking activity when protein-
encrypted but acquiring their biological effects when
proteolytically released, have been shown to have health-
promoting properties as anti-microbials, hypocholesterolemics,
opioid and opioid antagonists, angiotensin-converting
enzyme inhibitors, anti-thrombotics, immunomodulators,
cytomodulators, and anti-oxidants (Hayes et al., 2007b).
The human pool of digestive proteases and peptidases can
liberate food-encrypted bioactive peptides that can be absorbed
by the gut and then reach peripheral organs. However, the
enzymatic activity of LAB largely contribute to their release,
either into the food matrix (starter or autochthonous LAB) or in
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the gut (endogenous microbiota or probiotics). LAB are ancient
organisms adapted to an anoxic environment that never evolved
the capability to biosynthesize heme and hence to have functional
cytochromes, catalases, and peroxidases. They are very sensitive
to oxygen and devote most of their genes to oxygen stress
counteracting. Due to the limited length of the overall genome,
the biosynthetic abilities of LAB are very limited especially in
amino acid synthesis (Pessione, 2012). Therefore, LAB evolved
a complex and sophisticated proteolytic system allowing them
to get amino acids from the proteins present in the external
environment. A schematic representation of this system, which
includes proteases, peptidases and membrane transporters, is
referred in Figure 1.
LAB Proteolytic System
Extracellular protein hydrolysis into various long oligopeptides
is initiated by a cell-envelope proteinase (CEP). Oligopeptides
generated by this first cleavage are subsequently taken up
by cells via specific transport systems and they undergo
further degradation into shorter peptides (bioactive or possible
precursors of bioactive compounds) and amino acids in the
cytoplasm (Savijoki et al., 2006). In LAB the oligopeptide
transporter system (Opp) is the main transporter, belonging
to a superfamily of highly conserved ATP-binding cassette
transporters (Doeven et al., 2005). The Opp system of L. lactis
transports peptides up to at least 18 residues (Savijoki et al., 2006).
It should be underlined that most bioactive peptides are released
into the external environment only when cells undergo autolysis,
because only occasionally the longer peptides (originated by
the first hydrolytic step) possess biological activity (Meisel and
Bockelmann, 1999). Nevertheless, some authors reported that
CEP from Lactobacillus delbrueckii subsp. lactis are suitable
to liberate both metal-chelating and anti-hypertensive peptides
directly from caseins and without necessity of prior cell autolysis.
Maximum CEP activity was a little bit decreased by the addition
of NaCl (1%) and glycerol (5%; Hébert et al., 2008). However,
proteolytic enzymes released by LAB proved to be very different
in the different LAB species and strains, giving rise to a different
pool of bioactive peptides (Hébert et al., 1999).
Food Matrices Containing Encrypted
Peptides
Lactic acid bacteria proteolytic system is suitable to produce
bioactive peptides from several food proteins, especially
caseins that constitute the main nitrogen substrate present
in their habitat (milk and milk derivatives; Clare and
Swaisgood, 2000). Casein consists of four main proteins
(whose ratio is about 38:11:38:13): alpha s1 casein, alpha
s2 casein, beta-casein and k-casein, differing in amino
acid sequence, hydropathicity index, glycosylation and
phosphorylation degree (Pessione, 2012). Usually, CEPs
have a strong preference for hydrophobic caseins and
Lactococcus CEPs have been classified into several types
and subtypes depending on their substrate specificity for
αS1-, β-, and κ-caseins (Kunji et al., 1996). Casein hydrolysis can
give rise mainly to opioid/anti-opioid peptides, antithrombotic
and antihypertensive, immunomodulatory, mineral-binding and
antimicrobial peptides (Thakur et al., 2012) easily detectable
by means of chromatographic techniques after microbial food
digestion (Saraswat et al., 2012).
Hydrolytic cleavage of milk whey proteins (alpha-
lacto-albumine, beta-lacto-globulin, lactoferrin, and
immunoglobulins) can also generate bioactive molecules, such
as hypocholesterolemic peptides, which can decrease absorption
and enhance fecal extrusion of cholesterol. Actually, milk whey
proteins display a greater cholesterol-lowering activity than
casein, in particular beta-lactoglobulin (Nagaoka et al., 2001).
Beta-lactoglobulin-released peptides also exhibit antioxidant
(Hernández-Ledesma et al., 2005) and immune-modulating
(Prioult et al., 2004) activity.
Bio-active molecules, especially ACE-inhibiting peptides,
can also be found encrypted in bovine meat proteins, such
as hemoglobin (i.e., hemorphins) and serum albumin (i.e.,
serorphin), collagen, elastine, fibrinogen (Minkiewicz et al., 2011;
Lafarga et al., 2015).
However, also food of vegetal origin can be a source of
bioactive peptides. In soy β-conglycinin β-subunit (Kaneko
et al., 2010) and in the large subunit of spinach rubisco, both
antihypertensive (Yang Y. et al., 2003) and opioid peptides (i.e.,
soymorphins-5,-6, and -7, and rubiscolin-5 and -6, respectively),
displaying anxiolytic effects, food intake controlling action and
enhancement of memory, have been described (Yang et al., 2001;
Yang S. et al., 2003; Hirata et al., 2007).
A special mention needs gluten: opioid peptides (i.e., gluten
exorphins A4, A5, B4, B5, and C), have been detected and
characterized in wheat gluten since 1992 (Fukudome and
Yoshikawa, 1992). Some of these peptides have analgesic action
on the CNS (Takahashi et al., 2000) but some can also act
on opioid receptors located outside the blood–brain barrier,
inducing prolactin secretion (Fanciulli et al., 2005). Both
antihypertensive (Rizzello et al., 2008) and antioxidant (Coda
et al., 2012) peptides are the result of LAB activity on wheat and
other cereals. Generally, the high proline content of gluten alpha
gliadins prevent hydrolysis by enzymes of the gastrointestinal
tract, whereas LAB possess proline-specific peptidase systems.
Alternatively, peptide degradation is achieved by the combined
action of peptidase from different LAB strains simultaneously
present in fermented food (Gerez et al., 2008).
To date, LAB strains able to release bioactive peptides
from food proteins, with particular reference to milk caseins,
include L. helveticus CP790, L. rhamnosus GG, L. bulgaricus SS1,
and L. lactis subsp. cremoris FT4 (Gobbetti et al., 2002). The
hydrolytic ability is related to both the protein substrate, i.e.,
its amino acid sequence and the proteolytic enzyme panel of
each microbial strain (Griffiths and Tellez, 2013). It is possible to
enhance (100-fold) the proteolytic potential of LAB by growing
them in milk (Wakai and Yamamoto, 2012). Actually it has
been demonstrated that peptide-rich media like MRS supplying
a ready-to-eat nitrogen source are unfavorable to the induction
of most proteolytic enzymes for instance those encoded by Pep
N and PepX (Smeianov et al., 2007). On the other hand, CEP are
able to hydrolyze caseins only after growth on skim milk but not
after MRS pre-culture (Jensen et al., 2009). Generally, lactobacilli
genome encodes a larger number of proteases, peptidases, amino
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FIGURE 1 | Schematic representation of the proteolytic system of LAB.
acid permeases, and Opp transport systems than lactococci
(Klaenhammer et al., 2005). However, more studies on a larger
number of species and strains are necessary to establish the true
potential of each strain.
Finally, it is worth considering that most information on
LAB proteolytic system has been referred to food matrix isolated
microflora and to its action on bovine milk casein (Korhonen
and Pihlanto, 2003). However, endogenous or probiotic or food –
derived LAB can also produce bioactive peptides from the
different protein pool present in the host gut, opening interesting
perspectives for improving human health (Sharon et al., 2014).
In the following paragraphs, the best known bioactive molecules
generated from LAB proteases and peptidases are described.
Antimicrobial Peptides
Lactic acid bacteria proteolytic activity on caseins gives rise to
small peptides displaying antimicrobial (both bactericidal and
bacteriostatic) activity. Alpha s1 casein and K-casein hydrolysis
gives rise to isracidin and k-casecidin, respectively (McCann
et al., 2006). Both peptides display inhibitory action on S. aureus
growth (Meisel and Bockelmann, 1999; Atanasova et al., 2014).
K-casein can also originate kappacin, a long bioactive peptide
active against Streptococcus mutans. This peptide, although
deriving from K-casein, is phosphorylated but not glycosylated,
and displays the ability to prevent bacterial adhesion to gingival
mucosa and to bind enterotoxins (Malkoski et al., 2001). The
alpha-s-2 casein fragment 165-203, called casocidin-I can inhibit
both S. carnosus and E. coli (Zucht et al., 1995). Lactobacillus
helveticus can hydrolyze beta casein, by means of a PR4
proteinase, decrypting an antimicrobial peptide active toward
several strains of Gram-positive bacteria (including S. aureus
and Listeria innocua) but also against Gram-negative pathogens
such as E. coli, Salmonella, Yersinia, (Minervini et al., 2003).
Homology studies revealed that this peptide has a similar length
to isracidin, but a stronger hydrophobic nature (lacking positive
charges) allowing a better activity on Gram-negative bacteria.
Furthermore, it bears some proline residues near the C-terminal,
which can prolong its half-life rendering this molecule more
resistant to the peptidolytic action (Gobbetti et al., 2004). The
critical question concerning this peptide is that it has been
decrypted from human milk but not from other caseins present
in food (cow, buffalo, goat, ship).
Different peptides produced from caseins by different
Lactobacillus species (L. acidophilus, L. helveticus, L. plantarum,
and L. rhamnosus) and by Lactococcus lactis are active against
Gram-negative rods such as Enterobacter sakazakii (Hayes et al.,
2006). An interesting antimicrobial peptide, named Lactoferricin
B, having broad spectrum of action including Gram-negative
and Gram-positive bacteria, yeasts and filamentous fungi, has
been described as the result of the hydrolytic action on bovine
lactoferrin (Dionysius and Milne, 1997; Kitts and Weiler,
2003). This cationic peptide alters membrane permeability
with consequent dissipation of the proton gradient and has
therefore bactericidal action (FitzGerald and Murray, 2006). It
was cloned and expressed in E. coli, showing activity against
Klebsiella pneumoniae, Streptococcus Mutans, and S. aureus
(Luo et al., 2007). Lactoferricin B is especially active toward
the enterohemorrhagic strain of E. coli 0157h:7 (Muro-Urista
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et al., 2011) and proved to be active also against wine-
spoilage LAB such as Oenococcus oeni, Pediococcus damnosus,
and Lactobacillus brevis (Enrique et al., 2009). It is difficult
to establish the real LAB potential in hydrolyzing lactoferrin.
Some experiments were performed by using both microbial-
derived enzymes and fermentation with proteolytic starter
cultures (Sharma et al., 2011), however, the true potential of
each strain has to be experimentally proved since a great
variability was observed among strains (Korhonen, 2009). More
recently, the proteolytic activity of different LAB strains on goat
milk beta casein and beta-lactoglobulin were tested. Lactococcus
lactis l598, Lactobacillus lactis 1043, Streptococcus thermophilus
t3D1, Dt1and Lb. delbrueckii subsp. bulgaricus b38, b122 and
b24 revealed a significant potential in producing antimicrobial
peptides inhibiting S. aureus, L. monocytogenes, Listeria innocua,
Enterobacter aerogenes, and Salmonella enteritidis (Atanasova
et al., 2014).
Concerning the mechanism of action of such antibacterial
compounds, several models have been proposed. Being
amphipathic molecules, bearing a hydrophobic moiety and a
strongly positively charged domain, this peptides can firstly
bind to teichoic acids in Gram-positive-, or to LPS in Gram-
negative bacteria (Vorland, 1999) and then interact with the
negatively charged bacterial membranes. Most of them act as
proton gradient perturbing molecules, (causing membrane
depolarization like polymyxin B and colistin; Lohner and
Blondelle, 2005), however, some authors suggest that also
removal/chelating of membrane-bound iron can affect bacterial
viability (Sharma et al., 2011). For what concern lactoferrin-
derived peptides, however, it has long been established (Bellamy
et al., 1992) that the domains of lactoferrin involved in the
antibacterial activity are different from those involved in iron
binding. Complex mechanism, including inhibition of the
synthesis of macromolecules (Ulvatne et al., 2004) as well as
synergic action with host innate immunity compounds were also
reported (Brogden, 2005).
These antimicrobial compounds are appreciated in the food
industry (especially dairy industry) as natural preservatives
counteracting undesired contamination. This allows to reduce
the amount of sugar and salt with excellent benefits for diabetics,
obese, and hypertensive subjects. Furthermore, their stability in
blood and serum render them promising infection control agents.
Some of them are also good candidates to be tested for their anti-
viral potential. Bojsen et al. (2007) reported the antiviral effect of
bovine whey proteins, whereas Civra et al. (2015) very recently
identified from donkey milk lactadherin a peptide displaying
anti-Rotavirus activity. The actual role of LAB proteolysis in the
decrypting of the antiviral potential is far to be fully elucidated.
An overview of antibacterial peptides is proposed in Table 1.
Metal-Binding Peptides
Some LAB strains digest casein, releasing casein phosphopeptides
(CPP) phosphorylated on Ser residues. CPP have a strong anionic
character and hence are very resistant to further proteolytic
degradation (Sharma et al., 2011). They have been identified
during cheese ripening due to microbial protease activity (Singh
et al., 1997). The typical cluster is Ser(P)-Ser(P)Ser(P)-Glu-Glu,
but they may contain also phosphorylated cysteines. Even if
this motif is crucial for metal-binding, various phosphopeptide
fractions revealed significant differences in this capability, which
may be due to variant amino acid composition around the
phosphorylated region. Hence, other factors can affect CPP-metal
interaction, namely the total number of amino acids and the total
negative charge (Cross et al., 2005).
It has long been established (Gagnaire et al., 1996) that beta
and k-caseins (being poor in hydroxylated amino acids and
therefore less suitable for phosphorylation) generate peptides
less active in metal binding, whereas the Ser/Thr rich alpha s1
and alpha s2 caseins are the most suitable for chelating cations
by means of CPP. However, alpha s1 casein-derived peptide
(59–79), although bearing five phosphate groups, is less active
in allowing mineral uptake by the human tumor cells HT29
than beta casein-derived peptides (1–25). Actually, besides the
typical cluster sequence, specific secondary structure motifs in
the bioactive peptide (such as beta-turn and loop), as well as the
degree of aggregation of CPP in presence of divalent cations, are
required for a correct mineral absorption (Ferraretto et al., 2003).
Casein phosphopeptides can chelate up to 250 mgCa/g with
a dissociation constant in the mM range, with an affinity
even higher for trace elements like zinc, iron, and copper
(FitzGerald, 1998). Their mechanism of action rely on the fact
that they can form soluble complexes with calcium even at
alkaline pH (Berrocal et al., 1989). This results in increased
absorption of calcium in the intestine, useful in the treatment
of osteoporosis. Re-calcification of dental enamel and prevention
of dental caries were also reported (Reynolds et al., 2008).
Enhanced gut bioavailability and potential higher absorption
of enzyme co-factors such as iron, zinc, copper, selenium,
magnesium, and manganese, due to CPP was also described
(Meisel and Olieman, 1998). On the other hand, controversial
clinical results concerning both calcium (Korhonen and Pihlanto,
2006) zinc (Miquel and Farré, 2007) and calcium and iron
absorption obtained on patients receiving CPP supplementation
and controls, underline the difficulty to standardize the
different supplements (Teucher et al., 2006). Finally, calcium
availability is strongly dependent on meal composition (i.e.,
phytates) and complex interactions between different foods
ingested.
In spite of all these considerations, all described peptides
may constitute interesting tools for microelements nutritional
improvement. In our aging western society bone disease is
the third cause of nursery care and osteoporosis is not fully
controlled by a healthy lifestyle (active movement and diet;
Wei et al., 2003). Therefore, calcium-enriching supplements
such as CPP open new nutraceutical perspectives. However, the
need to use purified and well-characterized CPP (for having
a reproducible nutritional impact) highly affects the costs.
Hence, the use of LAB as probiotics or food supplements to
obtain functional food, especially milk based drinks and yogurts
will be a promising strategy. Lactobacillus helveticus LA, is
a LAB adapted to the cheese environment displaying good
proteolytic activity. It can decrypt from alpha casein a peptide
showing calcium-binding activity (Dimitrov, 2009). Lactobacillus
helveticus LBK16H can decrypt the tripeptides Ile-Pro-Pro and
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TABLE 1 | Main antibacterial peptides from LAB.
Bacteria Peptide Protein source Target Author
LAB Isracidin α s1-Casein S. aureus Meisel and Bockelmann, 1999
LAB k-Casedicin k-Casein S. aureus McCann et al., 2006
LAB Kappacin k-Casein S. mutans Malkoski et al., 2001
LAB Casocidin I α s2-Casein E. coli
S. carnosus
Zucht et al., 1995
L. helveticus Isracidin-like β-Casein S. aureus
L. innocua
Yersinia
Salmonella
Minervini et al., 2003
L acidophilus
L. helveticus
L. plantarum
L. rhamnosus
ND In toto casein Entobacteria sakazakii Hayes et al., 2006
ND Lactoferricin Cow lactoferrin K. pneumoniae
S. aureus
S. mutans
E. coli ol57
Luo et al., 2007; Muro-Urista et al., 2011
L lactis
L bulgaricus
L delbrueckii
S. thermophilus
ND Goat casein S. aureus
L. monocytogenes
L. innocua
Salmonella
Enterobacteria
Atanasova et al., 2014
L lactis
L bulgaricus
L delbrueckii
S. thermophilus
ND β-lactoglobulin S. aureus
L. monocytogenes
L. innocua
Salmonella
Enterobacteria
Atanasova et al., 2014
ND, not determined.
Val-Pro-Pro, both exerting anabolic effect on bones (Griffiths and
Tellez, 2013).
Antioxidant Peptides
The existence of antioxidant peptides in vegetal food (especially
cereals and legumes) is a well-established concept, recently
reviewed by Malaguti et al. (2014). Marine food, such as algae
(Sheih et al., 2009) and squid (Rajapakse et al., 2005b), as well
as unusual proteins like royal jelly-derived (Guo et al., 2009),
yak milk casein (Mao et al., 2011), goat milk casein (Li et al.,
2013), donkey milk (Piovesana et al., 2015), but also egg white
lysozyme (Rao et al., 2012), can be a source of antioxidant
peptides. Bacteria have the capability to decrypt antioxidant
peptides from several food proteins. Antioxidant activities were
described in fermented mussel sauce (Rajapakse et al., 2005a), in
LAB-fermented milk whey (Virtanen et al., 2007), in fermented
shrimps (Faithong et al., 2010), during sourdough fermentation
of wheat, rye, and kamut flours (Coda et al., 2012) and in
peptides derived from bovine casein after 24 h hydrolysis with
Bifidobacterium longum (Chang et al., 2013). Antioxidant efficacy
was also found in cell-free extracts of Lactobacillus plantarum
isolated from traditional Chinese food (tofu and kefir) but it is
rather related to pseudo catalase enzymes, exopolysaccharides
and lipoteichoic acids than to bioactive peptides (Li et al., 2012).
Recently, mixed cultures of LAB and yeast proved to be able
to produce antioxidant peptides from cow milk, however, the
peptide sequences having activity were not described (Li et al.,
2015).
Antioxidant peptides can control both enzymatic and non-
enzymatic peroxidation of fatty acids thus preventing membrane
lipid peroxidation (Hartmann and Meisel, 2007). They can act
as direct radical scavengers, non-radical oxygen quenchers or
metal chelators, but they also can eliminate radical precursors,
hence controlling ROS damage to cells and tissues, resulting in
a beneficial action on the whole organism. The redox balance
between ROS and antioxidant endogenous defenses is highly
impaired during chronic inflammation (Zhang et al., 2015)
thus, antioxidants are essential in controlling age-related chronic
degenerative diseases concerning both the cardiovascular and the
central nervous system.
Natural antioxidant peptides such as GSH (Cys-Glu-Gly)
or carnosine (beta-Ala-His) play important roles in radical
scavenging (Power et al., 2013). Antioxidant properties have
been demonstrated for Tyr, Trp, His, and Lys, in particular
when Tyr and Trp are in the C-terminus and the hydrophobic
residues Val and Leu at the N-terminus of a peptide.
Trp and Tyr behave as antioxidant molecules since their
indolic and phenolic groups can act as hydrogen donors
(Hernández-Ledesma et al., 2008). Basic amino acids can
chelate metallic ions and cysteine acts as a proton donor,
thanks to its thiolic group but the highest antioxidant activity
was demonstrated for the tripeptide Pro, His, His (Malaguti
et al., 2014). Furthermore it was demonstrated that Leu-His-
His and Pro-His-His can both act synergically with non-peptide
antioxidants such as butylated hydroxyanisole (Kitts and Weiler,
2003).
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Immunomodulatory Peptides
It is well established that some milk proteins (caseins,
whey proteins, lactoferrin, lactoperoxidase) are able to control
lymphocyte proliferation (Möller et al., 2008). Milk-derived
peptides such as the C-terminus sequence of beta casein (193–
209) can increase proliferation of rat lymphocytes (Meisel
and Bockelmann, 1999), whereas alpha casein C-terminal
hexapeptide (194–199) and beta casein fragments (63–68
and 91–93) induce macrophage maturation and phagocytosis
enhancement in vitro (Fiat and Jollès, 1989). In agreement
with these data, studies in vivo show that alpha casein-derived
peptides can stimulate macrophages phagocytosis exerting a
protective effect against Klebsiella pneumoniae infection in
mice (Migliore-Samour et al., 1989). Short-chain peptides
from milk whey proteins also stimulate the proliferation of
murine spleen lymphocytes in vitro (Mercier et al., 2004).
More detailed studies report that proliferation of human
peripheral blood lymphocytes is induced by the k-casein and
alpha lactalbumin fragment Tyr-Gly-Gly (Kayser and Meisel,
1996; Sharma et al., 2011). Natural killer (NK) cell activity
and antibody synthesis can also be enhanced by food–derived
bioactive peptides (Hartmann and Meisel, 2007). However, milk-
derived peptides do not act only as simply stimulators of
the immune system: immune-modulating activities including
cytokines regulation and attenuation of allergic reactions has also
been described (Korhonen and Pihlanto, 2003; FitzGerald and
Murray, 2006).
Transferring clinical data to food is not so simple.
Actually, in this scenario, LAB (especially probiotic LAB)
play a very central role: beta-casein medium fermented with
LAB gives rise to bioactive peptides acting on monocytes,
macrophages and T helper cells, particularly with Th1-
like cells (Laffineur et al., 1996). Lactobacillus paracasei
hydrolyzes beta-lactoglobulin originating peptides stimulating
Interleukin 10 (IL-10) production and downregulation of
IL-4 and gamma interferon secretion (Prioult et al., 2004).
Casein hydrolysated by Lactobacillus rhamnosus GG displays
modulating effects (both stimulation and suppression) on
lymphocyte proliferation (Möller et al., 2008). Furthermore,
casein hydrolysates from Lactobacillus rhamnosus GG can
induce enhancement of anti-inflammatory cytokines from
Th1 lymphocytes and a parallel decrease of pro-inflammatory
cytokines and immunoglobulins produced by Th2 lymphocytes,
thus controlling allergic reactions (Delcenserie et al., 2008).
Lactobacillus helveticus proteolysis products down-regulate
cytokines production and stimulate macrophage phagocytosis
(Matar et al., 2001) and also show protective effects against
E. coli O157 (LeBlanc et al., 2004) and Salmonella typhimurium
(Tellez et al., 2011) infection. All the non-proteolytic strains
of Lactobacillus helveticus failed to trigger immune system
modulation. Three immune-active peptides derived both from
beta casein and from alpha lactalbumin after milk fermentation
with proteolytic strains of Lactobacillus helveticus were analyzed:
they contain high percentage of proline histidine and lysine
(Tellez et al., 2010). Establishing how, when and in what extent
proteolysis occurs in food (and in the gut) is still an open
question.
Cell Cycle and Apoptosis Modulating
Peptides
Milk-derived peptides, sometimes resulting from microbial
proteolytic activity (Roy et al., 1999), can regulate cell growth,
differentiation, and apoptosis (Roy et al., 2002). De Simone
et al. (2008) demonstrated that waste milk whey is able to
induce apoptosis in CaCo2 cancer cells, but also interfere with
the cell cycle (reducing the number of cells in S-phase and
enhancing the number of cells in G1 phase), thus inhibiting
proliferation. Cooked milk whey loose this property probably due
to irreversible denaturation of proteases decrypting the peptides
of interest. The endogenous microflora of milk (both starters and
contaminating bacteria) seems to be the main responsible of the
phenomenon observed, since fresh milk does not exhibit this
behavior (De Simone et al., 2008). Although the involved peptides
were not characterized, it is very well known that some sequences
such as Arg-Gly-Asp-Asp-Asp-Asp-Asp-Asp-Asp-Asp-Asp can
have anti-proliferative effects on cancer cells models: the triplet
Arg-Gly-Asp can account for adhesion to the extracellular matrix
whereas the eight Asp residues can act intracellularly by binding
chromatin (Galvez and de Lumen, 1999). Meisel and FitzGerald
(2003) also demonstrated that normal cells are less sensitive to the
apoptotic induction than malignant cells. Tumor cells apoptosis
was also detected in an in vivo model in which mice were treated
with milk that underwent fermentation by a highly proteolytic
strain of Lactobacillus helveticus. On the contrary, the use of low-
proteolytic strains did not gave satisfactory results in terms of
breast cancer control in the same mice (De LeBlanc et al., 2005).
On the other hand, not all anticancer effects of milk are related
to proteolysis. It has been demonstrated that alpha lactalbumin
can form a complex with oleic acid in acid conditions. This
modified protein can induce apoptosis in cancer cells in vitro
(Svensson et al., 2000). Therefore, is it tempting to hypothesize
that acidification caused by LAB metabolism can also contribute
to these effects, and further experiments proving this will be
crucial to confirm such hypothesis and opening new perspectives
for cancer control. Taken together all these results suggest that it
is possible to increase host defenses against tumor degeneration
by using food fermented with LAB.
Opioid and Anti-opioid Peptides
These molecules constitute a promising frontier for treating
both stress-related behaviors such as anxiety and depression and
season-related mood disorders. They act on the appetite/satiety
as well, as demonstrated by Pfluger et al. (2012) who named
these molecules “nutropioids.” In general, these peptides are able
to control the gut–brain axis at several levels, including gut–
brain communication, brain cognitive function, and behavior
(Cryan and Dinan, 2012). Their mechanism of action includes
stimulation of receptors (K, delta, and mu) present in
both the central and the peripheral nervous system and
subsequent inhibition on adenylate cyclase activity. Some of these
compounds are summarized in Table 2.
The best studied myorelaxant peptides are beta-casomorphins
(which act on the mu receptors) and alpha s1 casein-derived
peptide (which acts on the delta receptor). Their primary
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TABLE 2 | Overview of the opioid and anti-opioid peptides.
Peptide Protein
source
Effect Receptor Author
β-Casomorphin β-Casein Opioid µ Loukas et al., 1983
ND α S1-Casein Opioid δ Loukas et al., 1983
Casoxin k-Casein Anti-opioid µk Chiba and
Yoshikawa, 1986
Exorphin B5I Gluten Opioid Out of the
BBB
Fukudome and
Yoshikawa, 1992
Soymorphine Soy Opioid µ Kaneko et al.,
2010
Rubiscolin Rubisco Opioid δ Yang et al., 2001
sequences consist of 4–10 amino acids whose N-terminal residue,
(essential to trigger biological activity), is Arg in alpha s1
casein-derived peptide and Tyr in beta-casomorphins (Loukas
et al., 1983). This difference, together with the presence of
six proline residues in beta-casomorphins, can account for
the higher resistance to enzymatic digestion of the latter,
resulting in enhanced half-life and absorption in human digestive
tract. Once in blood, beta-casomorphins can reach receptors
in the brain and in the peripheral tissues thus exerting a
relaxing action inducing calmness and sleeping (Chabance
et al., 1998). Another interesting peptide derived from alpha
s1casein is alpha-casozepine, displaying anxiolytic action but
not directly interacting with the mu and delta receptors. It
has been demonstrated that the biological effect is mediated by
activation of serotonin and GABAA receptors, causing release of
endogenous serotonin, dopamine, and GABA (Mizushige et al.,
2013). Conversely, casoxins peptides (originated from k-casein
hydrolysis) behave as opioid-antagonists over both the mu and
k-type receptors. Due to this different physiological role, casoxins
can be employed to counteract depression (Chiba and Yoshikawa,
1986).
Peptides produced with the contribution of LAB protease
system on dairy proteins are named exorphins and casoxins,
the former having opioid–like and the latter opioid-antagonist
function (Chabance et al., 1998). However, other foods may
contain opioid/anti-opioid peptides. It has long been established
that wheat gluten is a good source of opioid peptides (Fukudome
and Yoshikawa, 1992), and more recently, it has been shown
that gluten exorphin B5 can enhance prolactine secretion by
acting on receptors present outside the blood brain barrier.
In this case, the biological effect is linked to a reduced
dopaminergic tone (Fanciulli et al., 2005). Soymorphins are
very interesting opioid peptides acting on mu-receptors present
in the gut and connected with the serotonin, dopamine, and
GABA receptors systems. It was shown that soy-derived opioid
peptides act as anorexigenics and also reduce gastrointestinal
motility (Kaneko et al., 2010). A delta-opioid peptide called
rubiscolin was decrypted from the large subunit of spinach
rubisco (Yang et al., 2001). The rubiscolin amino acid sequence
is Tyr-Pro-Leu-Asp-Leu-Phe and it displays an analgesic effect
besides being involved in memory consolidation (Yang S.
et al., 2003). Hirata et al. (2007) also report anxiolytic action
of this natural peptide by activation of the sigma1 and D1
dopamine receptors, when delivered orally (100 mg/Kg). The
replacement of Leu3 with Ile or Met enhances by a factor four
the opioid activity, whereas the replacement of Phe with Val
potentiates the opioid activity more than 10-fold. The overall
activity of the sequence Tyr-Pro-Met-Asp-Leu-Val is 20 times
higher than the natural rubisco derivative (Yang S. et al.,
2003).
Antithrombotic Peptides
Blood coagulation occurs through a complex system of proteins
undergoing a sequential proteolytic cascade. These proteins
include pro-enzymes such as fibrinogen that is proteolytically
activated to fibrin by means of thrombin. Bovine k-casein derived
oligopeptides (fragment 106–116, 11 amino acids long) named
casoplatelins (or thrombin inhibitory peptides), can inhibit the
binding of human fibrinogen (gamma chain) on the platelet
surface receptor, due to sequence homology between fibrinogen
gamma chain and K-casein. Actually, the mechanism involved in
milk clotting, defined by interaction of k-casein with chymosin
bear a remarkable similarity to the process involved in blood
clotting, defined by interaction of fibrinogen with thrombin
(Qian et al., 1995). As a result, they prevent aggregation of
ADP-activated platelets. Also the glycopeptide present on the
N-terminus of k-casein, a smaller molecule called casopiastrin,
displays inhibiting activity on fibrinogen binding on the platelet
membrane (Ricci-Cabello et al., 2012). Although these molecules
are mainly the result of human proteolysis on milk, LAB
proteolytic activity on casein can contribute to their release both
in food and in vivo. Casoplatelins are present in high amounts in
the gut but, after absorption, significant concentrations are still
bio-available in blood thus contributing to thrombosis control in
humans.
Antihypertensive Peptides
Lactobacillus helveticus, Lactobacillus delbrueckii subsp.
Bulgaricus SS1, Lactobacillus delbrueckii subsp. lactis, and
Lactococcus lactis subsp. cremoris FT4 can modulate blood
pressure by producing angiotensin 1-converting enzyme
inhibitory peptides (ACE inhibitors) from milk proteins.
ACE is a carboxypeptidase converting angiotensin I (a
decapeptide) into angiotensin II (an octapeptide) having a
strong vasoconstrictor action (Hartmann and Meisel, 2007).
Lactobacillus delbrueckii subsp. lactis hydrolyzes both alpha s1
and beta casein (but not k-casein) by means of a cell envelope
proteinase releasing antihypertensive peptides: the proteolytic
activity was maximal during the logarithmic growth and
addition of NaCl and glycerol prevents correct proteolysis
(Hébert et al., 2008). Casein-derived anti-hypertensive
peptides are 2–6 amino acids long oligopeptides. Generally,
LAB peptidases, by shortening the poly/oligopeptide chain,
contribute to enhance the anti ACE potential. Actually the
6 (alpha s1 casokinin-6 = Thre-Thre-Met-Pro-Leu-Trp)
and the 5 (alpha s1 casokinin-5 = Phe-Phe-Val-Ala-Pro
and betacasokinin = Lys-Val-Leu-Pro-Val) amino acids long
oligopeptides are less active than the tripeptides made up of
Val-Pro-Pro and Ile-Pro-Pro. A very small dipeptide Tyr-
Pro, proved to be effective in blood pressure control as well
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(Yamamoto et al., 1999). The final active short peptides are
resistant to both pH variations and human digestive enzymes
thus opening interesting applicative perspectives (Gobbetti et al.,
2004).
Cholesterol-Lowering Peptides
Hypocholesterolemic peptides can be originated by beta-
lactoglobulin, casein and soy proteins proteolysis (Hori et al.,
2001). They can lower the total cholesterol of rats in vivo.
Their mechanism of action probably consists in the reduction
of the micellar cholesterol solubility or also to an enhanced
ability to bind taurocholate (Nagaoka et al., 2002). They
overall action prevents cholesterol absorption by CaCo2 cells
in vitro and enhances fecal steroid excretion in vivo. The
sequences displaying such activities are Ile-Ile-Ala-Glu-Lys, Ala-
Leu-Pro-Met-His and Gly-Leu-Asp-Ile-Gln-Lys (Nagaoka et al.,
2001).
Glucose-Uptake Stimulating Peptides
It has been demonstrated that dipeptides containing branched
chain amino acids (Ile-Ile, Leu Leu, Ile-Leu, Leu-Ile, Ile-
Val, Leu-Val, Val-Leu) can enhance glucose uptake in skeletal
muscle cells, favoring glycogen synthesis and thus controlling
hyperglycemia (Morifuji et al., 2010). Generally, glucose uptake
by skeletal muscle cells is induced by exercize-training by
means of increased expression or activity of key-signaling
proteins (Goodyear and Kahn, 1998). Branched-chain amino
acids are the main nitrogen source for skeletal muscles and
milk whey proteins are particularly rich in branched chain
amino acids (22.3%) as compared to caseins (20.3%), soy
proteins (17.5%), or wheat gluten (14.1%; Morifuji et al.,
2010). The dipeptide Ile-Leu is the most abundant after
milk whey hydrolysis. Therefore, assessing the proteolytic
activity of LAB toward milk whey proteins (that constitute
natural nitrogen substrates for LAB), is a promising strategy
to get nutritional supplements improving health. Proteomic
approaches using LC-MS-MS can be a valuable help for
identifying small nutritionally relevant peptides and a new
discipline, called food peptidomics, is now expanding (Lahrichi
et al., 2013).
Chaperone-Like Peptides
A very interesting class of protein-encrypted peptides are those
displaying chaperone-mimetic action (Bumagina et al., 2009;
Artemova et al., 2010). Synthetic peptides were constructed
on the model of bovine hemorphin-6, wheat gluten exorphin
C, and spinach rubiscolin-5 (all opioid peptides), and their
ability in refolding model proteins was investigated. The
target proteins to be refolded were heat-treated or DTT-
aggregated carbonic anhydrase, ADH and bovine milk alpha
lactoglobulin. The results clearly indicate that the peptides
are able to refold damaged proteins thus opening the way
to the interesting hypothesis that food proteins, besides
their nutritional role, can act as systems involved in quality
control of proteins especially during stress (Artemova et al.,
2010).
Mixed Function Peptides
Some food encrypted peptides, in case decrypted by LAB
proteolytic action, possess mixed function. In Table 3 are
reported the peptides displaying two or more biological activities.
As an example the tripeptides Val-Pro-Pro and Ile-Pro-Pro,
released from beta and K-casein by Lactobacillus helveticus are
immunomodulatory and hypotensive (Hartmann and Meisel,
2007). This effect can be explained by the fact that ACE inhibition
favors bradykinin production, and bradykinin plays a crucial role
in the inflammation process by stimulating macrophages and
increasing lymphokines secretion by lymphocytes (Sharma et al.,
2011).
Some immunostimulatory peptides also exhibit antimicrobial
features: beta-lactoglobulin-derived peptides can improve
phagocytosis but also stimulate the microbial autolytic system.
This is not only restricted to bacteria but also to fungi and both
naturally autolyzing and non-autolyzing strains are sensitive to
this effect (Hernández-Ledesma et al., 2008).
It has long been established that opioid peptides such as
casomorphin agonists also decrease cell proliferation by acting
on somatostatin receptors (Hatzoglou et al., 1996a,b). Since
opioid and somatostatin receptors are present on different cells
including central nervous, endocrine and immune system (De
Simone et al., 2008) the action of such peptides is more complex
than expected.
Several peptides are opioid and hypotensive, especially
those derived from bovine milk proteins (casomorphins,
lactorphins) and beta-casomorphin 7 is opioid, hypotensive, and
immunomodulatory: this last function is targeted on lymphocyte
proliferation that is sometimes stimulated and sometimes
inhibited depending on the peptide concentration (Meisel and
Bockelmann, 1999).
Lactoferricin, the lactoferrin-derived antimicrobial peptide,
besides being an antibacterial, antifungal and antiviral molecule,
can also control carcinogenesis by means of its anti-inflammatory
and immune-modulating properties. This effect seems to be due
to a positively charged region of the peptide that is very rich in
tryptophan and arginine residues (Sharma et al., 2011)
The reason of these mixed functions lies in the fact that
some regions in the primary structure of caseins contain
overlapping peptide sequences, exerting different physiological
functions (Meisel and Bockelmann, 1999). These domains, highly
hydrophobic and rich in proline residues, have been defined as
“strategic zones” and are resistant to proteolytic attack (Fiat and
Jollès, 1989).
In conclusion, of this paragraph it is important to underline
that not all bioactive peptides released by the combined
action of LAB proteolytic system and digestive proteases in
food and in the gut can be available for humans. Actually,
bioactive peptides may be degraded during digestion, may
be poorly absorbed and hence reach the target tissues at a
concentration lower than the one necessary to exert their
biological function. As far as degradation is concerned, supplying
bioactive peptides by means of GRAS bacteria (like LAB
are) plus protein complements is simpler than encapsulate
them and this constitutes therefore a promising strategy to
transport the molecules to the intestine, preventing degradation
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TABLE 3 | Overview of peptides with mixed functions.
Activity
Peptide Protein source Immuno-modulator Cell cycle Anti-ACE Opioid Anti-microbial Author
β-Casomorphin-7 (YPFPGPI) β-CN + + + Hatzoglou et al., 1996a,b
β-Casokinins-10 (YQQPVLGPVR) β-CN + + Hartmann and Meisel, 2007
α-Lactorphin (YGLF) α-LA + + Meisel and Bockelmann, 1999
β-Lactorphin (YLLF) β-LG + + Meisel and Bockelmann, 1999
Antimicrobial pept ide (AGTWY) β-LG + + Hernández-Ledesma et al., 2008
Immunopeptide (YGG) α-LA + + + Sharma et al., 2011
in the upper digestive tract. Efforts have been made also
to assess the real in vivo absorption of bioactive peptides:
blood levels of antihypertensive peptides have been quantified
(by LC ESI triple) after ingestion by human volunteers (van
Platerink et al., 2006) but also in vitro studies measuring
epithelial translocation across CaCo2 monolayers by means
of ESI-LC-MS-MS can supply reasonable information about
absorption. One challenging aspect of these approaches is the
need of improved “omics” methods aimed to identify low-
molecular weight bioactive peptides. MALDI (matrix-assisted
laser desorption ionization) TOF-MS has proved to be inadequate
because of matrix interference (Saavedra et al., 2013) and
matrix-free methods such as NALDI (nanostructure-assisted-
laser desorption ionization; Kütt et al., 2011) have been re-
proposed.
BIOACTIVE AMINES
A number of microorganisms synthesize, as decarboxylation
products of precursor amino acids, biogenic amines. In LAB,
expression (by transcriptional induction) and/or activation (by
catalytic modulation) of amino acid decarboxylation systems are
non-essential adaptive responses to energy depletion but also
strategies to counteract acid stress (Pessione, 2012).
However, not all biogenic amines are bioactive molecules
since most of them only act as spoilage compounds (putrescine,
cadaverine) sometimes enhancing the toxicity of true
bioactive molecules (Medina et al., 2003). On the contrary,
the decarboxylation of certain amino acids, as tyrosine and
histidine, can give rise to bioactive molecules (tyramine
and histamine) involved in several pathogenic syndromes,
more extensively described in the following paragraphs.
On the other hand, not all bioactive compounds negatively
affect human health: as an example, beta-phenylethylamine
derived from phenylalanine or tryptamine originated from
tryptophan can exert beneficial actions (such as mood control
and appetite/satiety balance regulation) when administered to
humans (Shimazu and Miklya, 2004). Similarly, it has been
reported that several LAB (L. bulgaricus, L. acidophilus, L. casei,
L. plantarum) can synthesize melatonin, a bioactive molecule,
deriving from tryptophan decarboxylation and serotonin
metabolism, acting on sleep and reproductive behavior but
also controlling immunity, inflammation and carcinogenesis
(Tan et al., 2014). A particular case is the glutamate product
gamma amino butyrate (GABA): this molecule can be naturally
present in food but also artificially added to enhance the
nutraceutical value of a certain food (GABA-tea, GABA-rice;
Abe et al., 1995; Oh, 2003) due to its relaxing action on
muscles and to its overall beneficial effects on the nervous
system.
Bioamines in Food
Cheese is the food most frequently associated with a too high
biogenic amine content. It is very rich in free amino acids due
to the desired proteolytic action performed by both bacteria and
fungi during “maturation,” when colonized by decarboxylase-
positive LAB (either autochthonous or contaminant bacteria)
it can be a source of tyramine, histamine, putrescine, and
beta-phenylethylamine (Pessione et al., 2009). Tyramine and
beta phenylethylamine are particularly abundant in food
from animal origin (including fermented sausages) since
these matrices are very rich in the precursor amino acids,
tyrosine, and phenylalanine, used by animals to synthesize
catecholamines. Both tyramine and beta-phenylethylamine are
bioactive compounds whose action will be better described in the
following paragraphs.
As far as fermented meat products are concerned, tyramine,
cadaverine, putrescine, and histamine can be found (Singh
et al., 2012). Poor quality processing favoring contamination
is the main cause of a too high bio-amine content of meat,
however starter strains possessing the capability to form biogenic
amines, like Lactobacillus curvatus, have been described as
well (Singh et al., 2012). To prevent such a risk, selection
of particular starter cultures possessing either amino oxidase
activity (Alvarez and Moreno-Arribas, 2014) or bacteriocin
synthesis capability (Somda et al., 2011) should be taken into
concern to contain the undesired consequences of spontaneous
fermentations.
Other fermented foods are alcoholic beverages such as beer,
ciders, and wine, that being of vegetal origin, are generally
poor of aromatic amino acid precursors (Lehtonen, 1996).
At the end of alcoholic fermentation the only amino acid
present in wine in significant amount is arginine (2,4 g/L):
this can be converted by the arginine decarboxylase into
agmatine and then putrescine, or rather be directed to
the arginine deiminase pathway (ADI) generating ammonia,
ornithine (generating putrescine) and carbamoyl phosphate
(Figure 2) (Costantini et al., 2013). Both putrescine and
ornithine are not true bioactive compounds even if they can
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FIGURE 2 | Schematic representation of the metabolic pathways
involved in putrescine formation. ADI, arginine deiminase; ADC, arginine
decarboxylase; AgDI, agmatine deiminase; ODC, ornithine decarboxylase.
alter the organoleptic properties of wine and enhance the
toxicity of other biogenic amines (Costantini et al., 2013).
Carbamoyl phosphate can combine with ethanol in wine
generating ethyl carbamate a carcinogenic molecule (Jiao et al.,
2014).
However, if the oenological procedures are not correctly
performed, other bioactive amines can be generated. Actually,
at the end of the alcoholic fermentation when all the grape
sugars are exhausted, yeast cells die and undergo autolysis,
releasing their own proteins and proteases (from lysosomes).
Hence, if dead yeasts cells are not immediately separated
from wine, free amino acids (from yeast proteins) become
available for autochthonous LAB able to perform malolactic
fermentation (MLF; Coton et al., 1999). This secondary
fermentation is widely appreciated for its improvement of
wine flavor, and it is usually performed by the predominant
species Oenococcus oeni or, more occasionally, by other LAB
species belonging to the genera Lactobacillus and Pediococcus,
which may develop during the winemaking process (Lonvaud-
Funel, 1999). Unfortunately, some LAB, besides TPP-dependent-
acid decarboxylases, also bear PLP-or pyruvoil-dependent
amino acid decarboxylases that can generate undesired amines,
depending on the precursor amino acid present at this
fermentation stage (Recsei and Snell, 1985). Therefore, histamine,
cadaverine, tyramine, and beta-phenylethylamine (whose action
will be better described in the following paragraphs) can be
produced.
The total content of biogenic amines in food varies from
1 to 50 mg/Kg (alcoholic and no-alcoholic beverages, soy
products) to 20–1,500 mg/Kg [sausages, cheeses; EFSA Panel
on Biological Hazards (BIOHAZ), 2011] At high concentrations,
BA are risk factors for food intoxication, while moderate levels
may lead to food intolerance (Ladero et al., 2010) It is very
difficult to establish a uniform maximum limit for ingested
BA since their toxic effect depends on the type of BA in
question. The unique BA for which the European Food Safety
Authority (EFSA) has legally set maximum limits is histamine
and only related to fish and fish products (Linares et al., 2016).
Furthermore, the toxic effects exerted by amines possessing
biological activity in humans, strongly depend on individual
sensitivity to them (Santos, 1996). As an example, tyramine
tolerance is lower in patients treated with antidepressant mono-
amino-oxidase inhibitory drugs (IMAO), which interact with
amino-oxidase enzymatic systems (MAO, DAO), since these
patients have an impaired ability to oxidize amines. For the
same reason, the toxic effects of bioactive amines in wine
consumers is enhanced by the presence of ethanol, which is one
of the most effective inhibitors of amine oxidases (Sessa et al.,
1984).
Factors Affecting Amines Production in
LAB
When considering the risk of bioactive amine release into
food, it is important to underline that maximum energy
depletion and acidification occurs during the stationary growth
phase. If (theoretically) LAB can be removed from food before
resting, no amine accumulation takes place. This statement
is supported by proteomic investigations that revealed that,
in L. hilgardii, histamine production is induced only during
stationary phase (Pessione et al., 2005). On the contrary, northern
blotting experiments showed activation of the HDC (histidine
decarboxylase) gene already during exponential growth phase
in a different L. hilgardii strain (Landete et al., 2008). However,
the same authors clearly demonstrated an inhibitory effect
of both glucose and fructose (still high during exponential
growth phase) over the genes coding for HDC in L. hilgardii,
O. oeni, and P. parvulus (Landete et al., 2008). Furthermore,
in both L. hilgardii and L. brevis, it has been demonstrated
that tyramine accumulation is maximal in presence of either
fructose or fructose plus L-malic acid (Moreno-Arribas et al.,
2003) thus supporting the idea that it is not necessary to
reach the stationary phase to trigger amine accumulation.
Actually, also in a different bacterial model (E. faecalis) studies
involving sub-proteomes profiling demonstrated a high tyramine
content already in the exponential phase when sugars are not
yet consumed (experiments performed in chemically defined
medium having glucose as sugar carbon source; Pessione et al.,
2009). Therefore, the evidences are still controversial and in part
related to specific amino acid/amine reaction, in part linked to a
strain difference.
A further strong evidence is the fact that amine production
is related to the availability of the precursor amino acid.
Supplements of tyrosine in the medium can increase about
10-fold tyramine accumulation and about twofold tyrosine
decarboxylase (TDC) activity in L. brevis (Moreno-Arribas
et al., 2000). Similarly, in Enterococcus faecalis, TDC was
found to be more abundant in the membrane extracts
when the strain was exposed to free tyrosine (Pessione
et al., 2009). Histamine is biosynthesized only in presence
of histidine: the cytosolic enzyme HDC was found more
abundant in cells grown in histidine medium (stimulated
condition) in Lactobacillus hilgardii, and Lactobacillus 30a
(Pessione et al., 2005; Mazzoli et al., 2009) as compared to control
conditions.
The only exception to this rule seems to be the GAD enzyme
that can allow GABA accumulation even in the absence of
glutamate. However, the chemically defined-medium medium
(CDM) used for growing L. lactis contains glutamine, so it is
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possible that part of it is converted to glutamate that can undergo
decarboxylation to GABA. On the other hand, a transcriptional
control exists since addition of glutamate can trigger a light
enhance of GABA biosynthesis (Mazzoli et al., 2010).
A critical concern connected with the necessity of free amino
acid availability is how bacteria can get them. As far as LAB
are concerned, often in the same ecological niche where they
live proteins are available (cheese) or microbial autolysis (wine)
generates free proteins that can undergo proteolytic breakdown
by LAB (Lamberti et al., 2011).
Interestingly, other factors can affect bioactive amine
production and, among these, acids (that can undergo or not a
similar decarboxylative process). It has been demonstrated that
L-lactic acid does not influence both histamine accumulation
and HDC biosynthesis (Landete et al., 2008). Similarly, malate
has no effect on histamine accumulation (Mangani et al.,
2005) or histidine consumption (Mazzoli et al., 2009). In
agreement with these data, Moreno-Arribas et al. (2000)
showed that tyramine production was not affected by either
malate or citrate, whereas Lonvaud-Funel (2001) observed
that both tyramine and histamine accumulation was lower
during MLF and higher after it. The utilization of the
amino acids tyrosine and histidine only after malate does
not necessarily indicate malate inhibition, but simply that
bacteria prefer utilize carbon sources before consuming nitrogen
compounds.
Other factors affecting amine accumulation in food include
temperature, spices and salt content, generally controlling
microbial growth. The optimum growth for most amine-
producing bacteria is 20–37◦C. Below this temperature, the
risk to find biogenic amines in food decreases (Karovicˇová
and Kohajdová, 2005). The sausage diameter as well
as the addition of spices can control a too high amine
content in meat: the larger the size, the higher the risk of
amines due to higher water activity and lower salt content.
However, NaCl not only negatively affects bacterial growth,
proteolytic activity and histidine decarboxylase activity but
also stimulates both tyrosine and glutamate decarboxylase
(GAD) synthesis acting as operon inducer (Singh et al.,
2012).
Histamine
The ingestion of histamine-rich food may cause heterogeneous
symptoms such as diarrhea, arrhythmia, headache, and allergic
syndromes such as respiratory distress (asthma), rhino-
conjunctivitis, urticaria, pruritus, and flushing (Manzotti
et al., 2016). Histamine is a strong hypotensive compound
also acting on many receptors present in the gastro intestinal
tract (Santos, 1996). Hence, high content of histamine is
responsible of the toxicity of spoiled or not properly stored
fish. In black carp fillets, for example, the contents of BAs
remained invariable during the early stages of storage and
began to increase at the later stages of storage occurs during
food storage. In particular, a significantly higher concentration
of histamine (132.05 mg/kg on the third day) was detected
in the black carp filets stored at 20◦C, indicating that this
temperature favors the formation of histamine (Hongbing
et al., 2016). In wines, especially red wines undergoing
spontaneous MLF by LAB, are frequently responsible of
these syndromes. Amino acids generating bioactive amines
(histidine, tryptophan, glutamate) can be released during the,
post-alcoholic fermentation, by yeasts autolysis as referred
above (Alexandre et al., 2001). The concentration of free
amino acids in wine is also dependent on the proteolytic
activity of the strain concerned with MLF (Alexandre et al.,
2001).
Tyramine
Tyramine is a bioactive molecule acting both at vascular level
(hypertension, vasal-constriction) and on the central nervous
system (headache). Despite it is generally assumed that histamine
is the most toxic BA, a recent work reveals that unexpectedly,
tyramine is more cytotoxic than histamine on an in vitro
model of the human intestinal epithelium. Furthermore, the
concentrations found to be toxic are commonly reached in BA-
rich foods (Linares et al., 2016). Severe syndromes have been
described in patients lacking a correct amino-oxidase activity
because in treatment with mono-amino-oxidase inhibitory
drugs (MAOI). MAOI are used as antidepressant because they
prevent the oxidative catabolism of brain-active amines, such
as dopamine, serotonin, tryptamine, and β-phenylethylamine.
Unfortunately, MAO-inhibitors cannot discriminate among
the different MAOs, and their overall effect results in high
concentrations of tyramine that can cause hypertensive crises,
brain hemorrhage and sometimes death (Pessione et al., 2009).
Since tyramine is the biogenic amine most frequently found
in cheese (due to the referred high tyrosine content of dairy
products) this syndrome is also called “cheese reaction.” For
the reasons explained above, MAOI development has led to
compounds with improved tolerability profiles compared to the
initial irreversible MAOIs, particularly in regard to tyramine-
induced hypertension and dietary restrictions (Yanez et al.,
2012). The huge number of non-controlled autochthonous
bacteria involved in cheese manufacturing and the accidental
contamination by unwanted strains during storage render
cheese a risky food for tyramine ingestion, although starters
are accurately typed. TDC activity has been described in
several LAB strains of the genera Lactobacillus, Carnobacterium,
and Leuconostoc. The enzyme from Lactobacillus brevis and
Enterococcus faecalis has been fully characterized. Proteomic
studies reveal the membrane location of such a protein in
Enterococcus faecalis (Pessione et al., 2009), thus confirming the
high hydrophobic nature of this enzyme (previously predicted
on the basis of gene analyses suggesting large hydrophobic
domains but also because of the harsh procedures needed to
purify it). Interestingly, Enterococcus faecalis TDC proved to be
able to produce not only tyramine from tyrosine but also beta-
phenylethylamine from phenylalanine (Pessione et al., 2009).
Beta-Phenylethylamine
β-Phenylethylamine, the decarboxylation product of
phenylalanine, behaves like an endogenous amphetamine.
It can control appetite/satiety thus being useful to treat obesity
and related syndromes as well as in weight-control diets. Like
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amphetamine it can also positively affect mood. However,
controversial effects including insomnia, anxiety, and a MAO-
blocking activity that may extend the half-life of tyramine thus
potentiating its toxicity (Millichap and Yee, 2003) have been
described. Evidence of a specific phenylalanine decarboxylase
enzyme in bacteria, has been reported only for Bacillus cohnii,
a species taxonomically distant from LAB. Nevertheless, both
Lactobacilli and Enterococci, frequently found in fermented food,
display a clear β-phenylethylamine accumulation. Originally,
some authors (Millichap and Yee, 2003) suggested that the
β-phenylethylamine found in fermented food is the result of
the activity of tyrosine decarboxylating bacteria. It is interesting
to underline that in mammals and in several eukaryotic cells
models a low-selective aromatic L-amino acid decarboxylase (EC
4.1.1.28) exists. In bacteria, enzymatic studies proved that TDC
from E. faecalis is active also toward DOPA, but not toward other
amino acids like phenylalanine while Lactobacillus bears a highly
tyrosine selective TDC. More recently, the presence in E. faecalis
of phenylalanine-decarboxylating TDC (EC 4.1.1.25) has been
clearly demonstrated by a bi-phasic kinetic of tyramine and
β-phenylethylamine production (Pessione et al., 2009). Tyrosine
is consumed first and it is fully converted into tyramine (during
logarithmic growth). Then phenylalanine is decarboxylated
to β-phenylethylamine, although with lower conversion rate
and yield. These results are consistent with a double catalytic
activity of the same protein (TDC) having higher specificity
for tyrosine and only low affinity for phenylalanine. On the
other hand, Marcobal et al. (2006) observed β-phenylethylamine
accumulation in a recombinant E. coli expressing the TDC gene
of E. faecium.
GABA
γ-Aminobutyric acid is one of the bioactive amines having true
positive effects on human health. It acts as a neurotransmitter
in the central nervous system of most vertebrates and plays
additional roles on the overall human physiology such as
lowering the blood pressure in mild hypertensive patients and
acting as smooth muscles relaxation system (Mazzoli et al.,
2010). Bacteria can produce GABA by the decarboxylation of
glutamate through GAD. Glutamate and GABA act as opposite
molecules having excitatory and inhibitory roles, respectively
(Hyland and Cryan, 2010). Lactococcus lactis NCDO 2118
can obtain GABA from glutamine opportunely converted into
glutamate (Mazzoli et al., 2010). It has long been established
that L. lactis possess only one gene encoding GAD and that
this enzymes is highly specific for glutamate (apparent Km
0.51 mM). Its molecular weight is about 54 kD and it has maximal
activity at pH 4.7, whereas no activity is present at neutral pH
(Nomura et al., 1999). Differences have been reported between
Lactococcus lactis subsp. lactis and L. lactis subsp. cremoris:
both possess gadCB genes encoding for GAD, however, one-
base deletion of adenine and one-base insertion of thymine were
detected in the coding region of the latter rendering it unable
to synthesize a functional GAD enzyme (Nomura et al., 2000).
Lactobacilli are the best GABA-producers, however, Lactococci,
Streptococci, and Bifidobacteria can synthesize GABA as well
(Lyte, 2011). Several strategies have been proposed to obtain high
GABA amounts from cheap substrates through LAB sourdough
fermentation (Coda et al., 2012), batch fermentation using
immobilized (Huang et al., 2007) or entrapped (Choi et al.,
2006) Lactobacillus brevis cells for the construction of functional
food. To achieve maximum GABA production, temperature
and pH are crucial (Dhakal et al., 2012). Nowadays, several
nutraceutical preparations, such as GABA tea (Abe et al., 1995),
GABA rice (Oh, 2003), GABA soymilk (Tsai et al., 2006),
and GABA chocolate (Nakamura et al., 2009) are available,
especially in Asia. GABA natural content of cacao is about
0.009%, however, this value is lower when considering the
market-available chocolate also containing milk, sugar, and other
ingredients. Functionalized chocolate, containing 0.28% GABA,
proved to be able to lower the level of salivary chromogranin A
and cortisol, thus reducing psychological stress (Nakamura et al.,
2009).
CONCLUSION
The knowledge on how, when and where bioactive amines are
produced by LAB present in fermented food will be helpful by
one side to prevent food borne diseases but on the other side also
to use food as a nutraceutical delivery system to control mood,
appetite and smooth muscle relaxation.
The knowledge about food-encrypted peptides and their
potential can offer, in the coming decades, new tools for
valuable therapies for the treatment of infectious diseases
as well as metabolic, nutritional and psychiatric disorders,
cardiovascular diseases, allergies and cancer, as suggested
by Lien and Lowman (2003). The increasing availability of
mass spectrometry facilities together with homology-based
identification of potential bioactive peptide domains on
protein sequences allows in silico prediction of encrypted
peptides and will in the future be essential for targeting the
right proteins. Several data banks are available for the bio-
informatics analysis of potential bioactive peptides (Iwaniak
et al., 2005; Lahrichi et al., 2013), especially antibacterial
peptides, due to the urgent issue to face antibiotic resistance
(Khaldi, 2012; Mooney et al., 2013). APD2 and CAMP
are databases set up to classify not only antibacterial but
also antifungal and antiviral peptides (Wang et al., 2009;
Thomas et al., 2010). An even larger target is supplied by
BIOPEP, Pep Bank, and Peptide DB, also classifying peptide
hormones, growth factors and cytokines (Shtatland et al.,
2007).
A new term, “nutritional peptidomics” has been proposed
by Panchaud et al. (2012) to underline the importance of
characterizing (mainly by mass spectrometry) food-encrypted
peptides displaying health effects. These approaches allow
to set up procedures to liberate the hidden bioactive
molecules by means of different proteolytic enzymes
(pepsin, trypsin, chymotrypsin) but also to synthesize
artificial peptides displaying bioactivity (Zambrowicz et al.,
2013). Microbial fermentation is one of the most promising
strategies to generate bioactive peptides, hence genomic
and proteomic characterization of new strains to predict
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their proteolytic profile is a challenging approach in view
of obtaining functional food. As far as LAB are concerned,
combining the substrate specificity and the cleavage pattern of
LAB proteases can highlight the strain potential to release health-
promoting molecules (or possible dangerous compounds) in food
(Hayes et al., 2007a,b). This is a valuable strategy for selecting
the right starters and to enhance the number of LAB strains to
be used as food additives or probiotics. Moreover, the use of
industrial by-products, such as milk whey, as growth substrates
can lower the cost of functional food production and furtherly
improve nutraceutical food availability.
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